Skip to main content

Table 4 Participant demographics

From: Implementation of HPV-based screening in Burkina Faso: lessons learned from the PARACAO hybrid-effectiveness study

 

All centers (N = 317)

Center A (N = 160)

Center B (N = 157)

p value

Age in years (%)

   

0.985

25–35 years old

153 (48.3)

78 (48.8)

75 (47.8)

 

36–45 years old

142 (44.8)

71 (44.4)

71 (45.2)

 

46–55 years old

22 (6.9)

11 (6.9)

11 (7.0)

 

Living area (%)

   

0.207

Ouagadougou

295 (97.0)

149 (95.5)

146 (98.6)

 

Outside Ouagadougou

9 (3.0)

7 (4.5)

2 (1.4)

 

Unknown

14 (4.4)

5 (3.1)

9 (5.7)

 

SES level (%)

   

< 0.001

High

111 (35.0)

47 (29.4)

64 (40.8)

 

Intermediate

162 (51.1)

79 (49.4)

83 (52.9)

 

Low

44 (13.9)

34 (21.2)

10 (6.4)

 

Screening history (%)

   

0.115

At least once

97 (30.6)

42 (26.2)

55 (35.0)

 

Never

220 (69.4)

118 (73.8)

102 (65)

 

Travel cost for screening process (%)a

   

0.095

None

59 (18.6)

33 (20.6)

26 (16.6)

 

Low

67 (21.1)

38 (23.8)

29 (18.5)

 

Intermediate

106 (33.4)

43 (26.9)

63 (40.1)

 

High

85 (26.8)

46 (28.7)

39 (24.8)

 

Literacy score (median (IQR))

10 (3)

10 (2)

11 (3)

0.692

  1. aTravel cost is the average amount of money spent by women traveling to healthcare centers during the screening process. It could be none (0$), low (≤ 0.90$), intermediate (≤ 1.80$) or high (> 1.80$). All cost are in US dollars